Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
uFSH for severe oligospermia or azoospermia
ChiCTR-IPR-14005647Phase 4Completed
- Sponsor
- Peking University Third Hospital
- Start
- Aug 2014
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of urofollitropin in oligospermia and azoospermia (2 arms), sponsored by Peking University Third Hospital. Primary endpoints: Hormonal level in vivo, Testicular volume and 4 more. Started Aug 2014; status: completed.
02
Drugs
urofollitropin
03
Conditions
oligospermiaazoospermia
Beyond the preview
Go deeper on ChiCTR-IPR-14005647.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-14005647.